Linearis Joins Two Canadian AI Health Data Projects
Linearis was selected for two projects under the Terry Fox Research Institute Digital Health Innovation Fund, the company said in a press release. The fund is investing a combined $40.9 million in 14 Canadian projects involving 55 partners.
The first project will combine genomic, proteomic, and metabolomic data with AI to predict treatments for people with lung, breast, or colorectal cancer. Partners include MRM Proteomics, Simmunome, the Jewish General Hospital, and Nova Scotia Health.
The second project, conducted with Nanil Therapeutics, will use standardized health data and AI to identify biomarkers for studying and monitoring neurodegenerative diseases. Both projects will use federated learning infrastructure that supports analysis across institutions without transferring the underlying data.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 16 Astrin Names Medical Director as Certitude Breast Expands Nationwide Sep 16 Amgen Selects Veeva Vault CRM for Global Deployment Sep 16 Medallion Acquires Andros for Healthcare Credentialing Sep 16 SENA Health Raises Series A for AI Care Coordination Sep 16 Notable Names Nicholas Desai Chief Medical OfficerLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Radical Ventures Secures Over $1 Billion for AI Fund
Probably Genetic Gets Up to $10M ARPA-H Contract for Rare Disease AI
HiRO and Differentia Biotech Sign MOU for AI Clinical Trial Simulation
Canada and Germany Commit Up to C$300 Million to LawZero
Jetstream Venture Fund Invests in ImageAiD and Moonrise Medical
Daily AI Brief: the AI news that matters, in your inbox.